Cargando…

Transglutaminase 2 and Ferroptosis: a new liaison?

Detalles Bibliográficos
Autores principales:	Gagliardi, Mara, Saverio, Valentina, Rossin, Federica, D’Eletto, Manuela, Corazzari, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998634/ https://www.ncbi.nlm.nih.gov/pubmed/36894531 http://dx.doi.org/10.1038/s41420-023-01394-1

Ejemplares similares

Type 2 transglutaminase in the nucleus: the new epigenetic face of a cytoplasmic enzyme
por: Rossin, Federica, et al.
Publicado: (2023)

Transglutaminase type 2-dependent crosslinking of IRF3 in dying melanoma cells
por: Occhigrossi, Luca, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease severity is modulated by transglutaminase type 2
por: Piacentini, Mauro, et al.
Publicado: (2018)

The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation
por: Altuntas, Sara, et al.
Publicado: (2015)

The Multifaceted Role of HSF1 in Pathophysiology: Focus on Its Interplay with TG2
por: Occhigrossi, Luca, et al.
Publicado: (2021)

Transglutaminase Type 2 regulates the Wnt/β-catenin pathway in vertebrates
por: Rossin, Federica, et al.
Publicado: (2021)

Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states
por: Piacentini, Mauro, et al.
Publicado: (2014)

Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma
por: Muccioli, Silvia, et al.
Publicado: (2023)

Reticulon Homology Domain-Containing Proteins and ER-Phagy
por: D’Eletto, Manuela, et al.
Publicado: (2020)

Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis
por: Gagliardi, Mara, et al.
Publicado: (2019)

Wild-type and mutant p53 in cancer-related ferroptosis. A matter of stress management?
por: Corazzari, Marco, et al.
Publicado: (2023)

Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation
por: Ferrari, Eleonora, et al.
Publicado: (2017)

The STING/TBK1/IRF3/IFN type I pathway is defective in cystic fibrosis
por: Occhigrossi, Luca, et al.
Publicado: (2023)

Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy
por: Alonzi, Tonino, et al.
Publicado: (2021)

A Gut-Ex-Vivo System to Study Gut Inflammation Associated to Inflammatory Bowel Disease (IBD)
por: Gagliardi, Mara, et al.
Publicado: (2021)

Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
por: Palucci, Ivana, et al.
Publicado: (2023)

Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate
por: Corazzari, Marco, et al.
Publicado: (2017)

The Gut-Ex-Vivo System (GEVS) Is a Dynamic and Versatile Tool for the Study of DNBS-Induced IBD in BALB/C and C57BL/6 Mice, Highlighting the Protective Role of Probiotics
por: Monzani, Romina, et al.
Publicado: (2022)

Difficulties in interpreting patient-reported outcome measures in the absence of a gold standard: the meaning of Clinical Global Impressions scores in liaison psychiatry
por: Valaiyapathi, Rajalakshmi, et al.
Publicado: (2021)

Probiotics Supplements Reduce ER Stress and Gut Inflammation Associated with Gliadin Intake in a Mouse Model of Gluten Sensitivity
por: Ferrari, Eleonora, et al.
Publicado: (2021)

Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease
por: Esposito, Speranza, et al.
Publicado: (2019)

Occurrence and Antimicrobial Susceptibility Profiles of Streptococcus equi subsp. zooepidemicus Strains Isolated from Mares with Fertility Problems
por: Nocera, Francesca Paola, et al.
Publicado: (2021)

Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype
por: Gates, Eric W. J., et al.
Publicado: (2023)

Liaisons
por: International Organization for Standardization. Geneva
Publicado: (1982)

New insight into transglutaminase 2 and link to neurodegenerative diseases
por: Min, Boram, et al.
Publicado: (2018)

New directions for academic liaison librarians
por: Crawford, Alice
Publicado: (2012)

Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
por: Xie, Yizhao, et al.
Publicado: (2022)

Gorenstein liaison, complete intersection liaison invariants and unobstructedness
por: Kleppe, Jan O, et al.
Publicado: (2001)

Transglutaminase 2 in human diseases
por: Szondy, Zsuzsa, et al.
Publicado: (2017)

Biological Functionalities of Transglutaminase 2 and the Possibility of Its Compensation by Other Members of the Transglutaminase Family
por: Odii, Benedict Onyekachi, et al.
Publicado: (2014)

Asthma and COVID-19: a dangerous liaison?
por: Lombardi, Carlo, et al.
Publicado: (2021)

Transglutaminase 2—a novel inhibitor of adipogenesis
por: Myneni, V D, et al.
Publicado: (2015)

Dangerous liaisons: MYCN meets condensins
por: Achar, Yathish Jagadheesh, et al.
Publicado: (2014)

New Insights into Development of Transglutaminase 2 Inhibitors as Pharmaceutical Lead Compounds
por: Kim, Soo-Youl
Publicado: (2018)

Activation and Inhibition of Transglutaminase 2 in Mice
por: Dafik, Laila, et al.
Publicado: (2012)

Biochemical and Functional Characterization of the Three Zebrafish Transglutaminases 2
por: Lisetto, Manuel, et al.
Publicado: (2023)

Liaison interpreting : a handbook
por: Gentile, Adolfo
Publicado: (1996)

Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: Dangerous Liaisons
por: Sini, Paola, et al.
Publicado: (2021)

Liaisons Dangereuses? new drugs, physicians and the drug industry
por: Gale, Robert Peter, et al.
Publicado: (2020)

The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients
por: Vicenzi, Marco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l4mk5740o4ib52quhaf1akhkad